BPOM、Bio-TCV インドネシアを通じて国家ワクチンの独立性を促進
食品医薬品監督庁（BPOM）は、学術、産業界、政府の協力によって開発された革新的な結合型腸チフスワクチンであるBio-TCVの発売を通じて、国家ワクチンの独立性の実現を奨励しています。 Bio-TCV は、インドネシア大学医学部 (FKUI)、チプト マングンクスモ病院 (RSCM)、および PT Bio Farma の協力の成果です。
This article requires PRO
This article is outside the free access window or is a special report. PRO unlocks it and the full archive.
Related articles
- Indonesia Releases 2026 Education Sector Corruption Prevention Strategy, Cites Thesis Ghostwriting and Plagiarism
Indonesia's Corruption Eradication Commission (KPK) has launched its 2026 Education Sector Corruption Prevention Strategy (SPI Pendidikan 2026). The strategy addresses issues such as thesis ghostwriting and plagiarism, aiming to strengthen countermeasures against academic dishonesty.
- Former Lombok Islamic Boarding School Leader Named Suspect in Sexual Assault Case
A former leader of an Islamic boarding school (Ponpes) in Lombok, Indonesia, has been named a suspect in a sexual assault case. The number of alumni reporting themselves as victims has risen to 17, following the case's virality on social media.
- Explosion at Surabaya Eatery Injures 5 Employees, Facial Burns Reported
An explosion at a restaurant in Surabaya has left five employees with facial burns. Police are investigating a potential gas leak from large LPG cylinders as the likely cause. The blast also damaged surrounding buildings and vehicles.
- Indonesia Faces Concern Over Excessive University Programs, Urges Consolidation
Indonesia's Minister of Higher Education, Science, and Technology has expressed concern over the excessive number of university programs (prodi). In 2025, there were 34,711 programs, with a significant concentration in private institutions. The minister advocates for program consolidation to streamline administration and accreditation.